Physician profile
Fahd R Khan
NPI 1174731095
$11,316.95
in general payments reported to CMS, 2019-2025
23 companies · $1,605 in 2025
The $1,605 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $373 · 2021: $1,141 · 2022: $772 · 2023: $891 · 2024: $5,071 · 2025: $1,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,450 · Travel and Lodging: $2,077 · Education: $39.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,449.67 |
| Travel and Lodging | $2,076.96 |
| Education | $39.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $3,015.32 | 2023-2025 | Exablate |
| Boston Scientific Corporation | $2,011.67 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Dbs |
| Abbott Laboratories | $1,766.19 | 2019-2025 | Eterna, Proclaim, Infinity |
| Neuropace, INC. | $1,578.10 | 2023-2024 | |
| Medtronic USA, INC. | $756.71 | 2019-2020 | |
| Medtronic, INC. | $545.57 | 2021-2024 | Percept PC Brainsense, Intellis Adaptivestim, Stealthstation S8 Platform |
| Painteq LLC | $410.72 | 2021-2024 | Painteq |
| Nevro Corp. | $349.54 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $184.71 | 2024 | Andexxa |
| Gt Medical Technologies, INC | $117.98 | 2019 | |
| Globus Medical, INC. | $109.67 | 2023-2025 | Senza, Vyrsa V1, Excelsiusgps Robotic Navigation System |
| Novocure INC. | $104.20 | 2024 | Optune |
| Nalu Medical, INC. | $68.52 | 2021-2025 | Nalu Neurostimulation System |
| Livanova USA, INC. | $67.73 | 2019-2021 | |
| Integra Lifesciences Corporation | $50.50 | 2020-2024 | Codman Certas, Cusa Clarity, Codman Hakim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $35.67 | 2021 | |
| Ethicon US, LLC | $30.62 | 2022-2023 | Evarrest |
| Bioventus LLC | $26.07 | 2022 | |
| Kls-Martin L.P. | $20.69 | 2023 | |
| Nuvasive, INC. | $19.28 | 2022 | |
| Monteris Medical Corporation | $19.25 | 2022 | |
| Providence Medical Technology, INC. | $15.48 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahd Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.